Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily Journal Article
| Author: | Moskowitz, C. H. |
| Article Title: | Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily |
| Keywords: | radiotherapy; therapy; stem-cell transplantation; phase-ii; working party; european group; marrow-transplantation; involved field; brentuximab vedotin; pd-1 blockade; refractory hodgkin lymphoma |
| Journal Title: | Blood Advances |
| Volume: | 2 |
| Issue: | 7 |
| ISSN: | 2473-9529 |
| Publisher: | American Society of Hematology |
| Date Published: | 2018-04-10 |
| Start Page: | 821 |
| End Page: | 824 |
| Language: | English |
| ACCESSION: | WOS:000430751400012 |
| DOI: | 10.1182/bloodadvances.2017011130 |
| PROVIDER: | wos |
| PMCID: | PMC5894256 |
| PUBMED: | 29636328 |
| Notes: | Editorial Material -- Source: Wos |
